Stock Fundamentals

Company Information

Company Name
Verrica Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US92511W1080
CIK: 0001660334
CUSIP: 92511W108
Currency: USD
Full Time Employees: 76
Phone: 484 453 3300
Fiscal Year End: December
IPO Date: Jun 15, 2018
Description:

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Address:

44 West Gay Street, West Chester, PA, United States, 19380

Directors & Officers

Name Title Year Born
Dr. Jayson M. Rieger M.B.A., Ph.D. President, CEO & Director 1976
Mr. John J. Kirby CPA Interim Chief Financial Officer 1972
Dr. Noah L. Rosenberg M.D. Chief Medical Officer 1967
Mr. David Zawitz COO, Chief Legal Officer & Secretary 1981
Mr. Eugene Scavola Executive Vice President of Technical Operations NA
Dr. Bradley J. Catalone MBA, Ph.D. Head of Drug Development NA
Mr. Chris Chapman Chief Commercial Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 25, 2025 David Zawitz N/A Purchase 10.00K $4.24 $42.40K
Nov 25, 2025 Jayson Rieger N/A Purchase 94.31K $4.24 $399.88K
Nov 25, 2025 John J Kirby N/A Purchase 3.54K $4.24 $14.99K
Nov 25, 2025 Noah L Rosenberg N/A Purchase 2.36K $4.24 $9.99K
Nov 25, 2025 Paul B Manning N/A Purchase 1.38M $4.24 $5.83M
Nov 25, 2025 Paul B Manning N/A Purchase 2.75M $4.24 $11.66M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Caligan Partners LP 923.91K Mar 31, 2026 5.38% $0.33 0.00%
Affinity Asset Advisors, LLC 707.34K Mar 31, 2026 4.12% $0.19 0.00%
Cannell Capital LLC 685.12K Mar 31, 2026 3.99% $2.23 0.00%
Armistice Capital, LLC 518.18K Mar 31, 2026 3.02% $0.05 -53.69%
Velan Capital Investment Management LP 471.56K Mar 31, 2026 2.75% $1.56 0.00%
BOOTHBAY FUND MANAGEMENT, LLC 280.73K Mar 31, 2026 1.63% $0.02 0.00%
Vanguard Capital Management, LLC 188.76K Mar 31, 2026 1.10% $0.00 0.00%
Dafna Capital Management LLC 153.71K Mar 31, 2026 0.89% $0.19 -11.38%
Marshall Wace Asset Management Ltd 140.50K Mar 31, 2026 0.82% $0.00 64.95%
Geode Capital Management, LLC 138.92K Mar 31, 2026 0.81% $0.00 105.32%
Vanguard Group Inc 138.19K Dec 31, 2025 0.80% $0.00 -38.64%
Stonepine Capital Management Llc 99.74K Mar 31, 2026 0.58% $0.21 -71.80%
Squarepoint Ops LLC 75.21K Mar 31, 2026 0.44% $0.00 126.05%
Vanguard Fiduciary Trust Co 65.10K Mar 31, 2026 0.38% $0.00 0.00%
Two Sigma Investments LLC 50.66K Mar 31, 2026 0.29% $0.00 -57.15%
Jane Street Group LLC 49.21K Mar 31, 2026 0.29% $0.00 -51.62%
Two Sigma Advisers, LLC 44.43K Dec 31, 2025 0.26% $0.00 0.00%
BlackRock Inc 38.55K Mar 31, 2026 0.22% $0.00 578.15%
Renaissance Technologies Corp 32.36K Mar 31, 2026 0.19% $0.00 22.58%
Northern Trust Corp 31.58K Mar 31, 2026 0.18% $0.00 57.71%

Shares Statistics

Shares Outstanding: 17.18M
Shares Float: 7.90M
% Insiders: 4,875.10%
% Institutions: 2,787.00%
Short % Float: 4.29%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Institutional Extnd Mkt Idx Tr 135.94K 0.79% ▲ 0.00% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 104.71K 0.61% ▲ 98.23% Apr 30, 2026
3 Fidelity Extended Market Index 67.85K 0.39% ▼ 0.36% Apr 30, 2026
4 Blackrock Extended Mkt Fund CF 37.42K 0.22% ▲ 0.00% Apr 30, 2026
5 BlackRock Extended Equity Market Fund K 31.86K 0.19% ▲ 653.82% Mar 31, 2026
6 Fidelity Series Total Market Index 17.06K 0.10% ▲ 0.00% Apr 30, 2026
7 Spartan Extended Market Index Pool F 16.79K 0.10% ▲ 1.50% Apr 30, 2026
8 Fidelity Total Market Index 15.77K 0.09% ▲ 0.00% Apr 30, 2026
9 NT Ext Equity Mkt Index Fund - Lending 14.11K 0.08% ▲ 93.05% Mar 31, 2026
10 Northern Trust Extended Eq Market Idx 14.11K 0.08% ▲ 93.05% Mar 31, 2026

Valuation Metrics

Enterprise Value: $79.28M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $98.43M
EBITDA: $-13.06M
Book Value: $0.94
Earnings/Share: $-1.10
Profit Margin: -47.97%
Operating Margin: -193.41%
ROA (TTM): -20.88%
ROE (TTM): -240.36%
Revenue (TTM): $37.16M
Revenue/Share (TTM): $2.73
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 46.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.59x 0.03x 0.48x -1.54x -0.08x
2024-12-31 1.76x -4.52x 1.18x -7.00x -0.68x
2023-12-31 4.55x 2.20x 0.76x -16.60x -0.70x
2022-12-31 11.31x 0.01x 0.10x -9.80x -0.01x
2021-12-31 1.61x 1.29x 0.59x -7.20x -1.38x
2020-12-31 1.71x 2.15x 0.56x -13.25x -1.80x
2019-12-31 19.39x 0.00x 0.05x N/A 0.00x
2018-12-31 36.80x 0.00x 0.03x N/A 0.00x
2017-12-31 14.75x 0.00x 1.78x -2,228.50x 0.00x
2016-12-31 1.30x -0.01x 5.90x N/A -0.02x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about VRCA.US!